Literature DB >> 6489100

Disturbances of ocular motility after retinal detachment surgery.

M Peduzzi, E C Campos, F Guerrieri.   

Abstract

In a series of 562 patients who underwent surgery for retinal detachment, 17 (3.02%) had significant post-operative muscle imbalance. On the basis of the patients histories and clinical examinations, it is possible to classify the disturbances of ocular motility according to the symptoms (type, time of onset) and the pathogenesis (lesion of muscular sheats or bodies, capsulo-conjunctival cicatricial retractions, prolonged muscular compression, decompensation of pre-existing squints). If diplopia does not cease spontaneously, treatment consists of use of temporary prisms, but in some cases surgery is required.

Entities:  

Mesh:

Year:  1984        PMID: 6489100     DOI: 10.1007/bf00140908

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  5 in total

1.  [Changes in ocular motility after scleral resection].

Authors:  R WEEKERS; J DELVILLE-HACOURT; M WATILLON
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1958-06

2.  [Oculomotor disorders after surgery for retinal detachment].

Authors:  R G FREY
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1955

3.  Diplopia after retinal detachment surgery.

Authors:  J J Kanski; A R Elkington; M S Davies
Journal:  Am J Ophthalmol       Date:  1973-07       Impact factor: 5.258

4.  [Oculomotor complications after cerclage].

Authors:  F Déodati; P Bec; G Béchac
Journal:  Bull Soc Ophtalmol Fr       Date:  1972 Jul-Aug

5.  Binocularity after retinal detachment surgery.

Authors:  A Arruga
Journal:  Doc Ophthalmol       Date:  1973-02-21       Impact factor: 2.379

  5 in total
  2 in total

1.  Diplopia after retinal detachment surgery.

Authors:  P N Fison; A H Chignell
Journal:  Br J Ophthalmol       Date:  1987-07       Impact factor: 4.638

2.  [Diplopia after encircling procedure for retinal detachment].

Authors:  A Langmann; A Gruber; S Lindner; G Langmann
Journal:  Ophthalmologe       Date:  2003-08       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.